Atrys Health, S.A. (BME:ATRY)
Spain · Delayed Price · Currency is EUR 2.670
-0.030 (-1.11%)
Dec 5, 2025, 11:16 AM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €204.86 million as of December 5, 2025. Its market cap has decreased by -15.43% in one year.
Market Cap
204.86M
Enterprise Value
441.43M
Revenue
226.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.67
Market Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 204.86M, an increase of 1,048.00%. That is a compound annual growth rate of 29.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 204.86M | -19.95% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | 298.55M | 163.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.40B |
| Laboratorios Farmaceuticos Rovi | 3.07B |
| Almirall | 2.72B |
| Faes Farma | 1.48B |
| Pharma Mar | 1.26B |
| Clínica Baviera | 755.77M |
| Oryzon Genomics | 257.06M |
| Prim, S.A. | 228.01M |